These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8785980)

  • 1. Evaluation of the Leptospira pomona ELISA and its correlation with the hamster potency assay.
    Ruby KW
    Dev Biol Stand; 1996; 86():340. PubMed ID: 8785980
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of an in vitro assay for measuring the relative potency of leptospiral bacterins containing serovar canicola and its correlation to the hamster potency assay.
    Ruby KW; Walden DM; Wannemuehler MJ
    Dev Biol Stand; 1996; 86():341. PubMed ID: 8785981
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of an enzyme-linked immunosorbent assay for potency testing of erysipelas bacterins.
    Henderson LM; Scheevel KF; Walden DM
    Dev Biol Stand; 1996; 86():333. PubMed ID: 8785973
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful development and validation of an in vitro replacement assay for Leptospira vaccine potency tests.
    Kulpa-Eddy J
    Dev Biol (Basel); 2012; 134():101-6. PubMed ID: 22888601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of protective erysipelas antibodies in pig and mouse sera as possible alternatives to the animal challenge models currently used for potency tests.
    Beckmann R; Gyra H; Cussler K
    Dev Biol Stand; 1996; 86():326. PubMed ID: 8785966
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of in vitro assays for measuring the relative potency of leptospiral bacterins containing serogroups canicola, grippotyphosa, icterohaemorrhagiae, and pomona.
    Ruby KW; Srinivas GB
    Biologicals; 2013 Sep; 41(5):308-14. PubMed ID: 23870804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USDA regulatory guidelines and practices for veterinary Leptospira vaccine potency testing.
    Srinivas GB; Walker A; Rippke B
    Biologicals; 2013 Sep; 41(5):298-302. PubMed ID: 23838570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and strategies to further reduce animal use for Leptospira vaccine potency testing.
    Walker A; Srinivas GB
    Biologicals; 2013 Sep; 41(5):332-7. PubMed ID: 23891496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay for measuring relative potency of leptospiral bacterins containing serovar pomona.
    Ruby KW; Cardella MA; Knudtson WU
    Biologicals; 1992 Dec; 20(4):259-66. PubMed ID: 1305402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the vaccine potentiality of 2 strains from Leptospira interrogans serogroup Ballum].
    Rodríguez AG; Jiménez YR; Santiesteban NB; Abreu YV; Osenes JF; González MG
    Rev Cubana Med Trop; 2005; 57(1):63-4. PubMed ID: 17966485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report on the international workshop on alternative methods for Leptospira vaccine potency testing: state of the science and the way forward.
    Stokes W; Srinivas G; McFarland R; Kulpa-Eddy J; Casey W; Walker A; Draayer H; Sebring R; Brown K; Balks E; Stirling C; Klaasen E; Hill R; Rippke B; Ruby K; Alt D; Mukhopadhyay S; Kojima H; Johnson N; Rinckel L; Doelling V; Jones B
    Biologicals; 2013 Sep; 41(5):279-94. PubMed ID: 23890729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Would an in vitro ELISA test be a suitable alternative potency method to the in vivo immunogenicity assay commonly used in the context of international Hepatitis A vaccines batch release?
    Poirier B; Variot P; Delourme P; Maurin J; Morgeaux S
    Vaccine; 2010 Feb; 28(7):1796-802. PubMed ID: 20018270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Product-specific validation of a serological potency test for release of Leptospira vaccines in the European Union.
    Stirling C; Novokova V
    Biologicals; 2013 Sep; 41(5):330-1. PubMed ID: 23849308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a monoclonal antibody for in vitro potency testing of erysipelas bacterins.
    Henderson LM; Jenkins PS; Scheevel KF; Walden DM
    Dev Biol Stand; 1996; 86():334. PubMed ID: 8785974
    [No Abstract]   [Full Text] [Related]  

  • 15. A serological potency assay for Clostridium chauvoei.
    Hauer PJ; Whitaker MS; Henry LA
    Dev Biol Stand; 1996; 86():331. PubMed ID: 8785971
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on avirulent Leptospira pomona live vaccine in swine (author's transl)].
    Wang SQ; Zhang RZ; Li ZH; Liu YM; Tan MW; Zhang JS; Yang BJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1979 Sep; 1(1):87-92. PubMed ID: 262819
    [No Abstract]   [Full Text] [Related]  

  • 17. Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation.
    Redhead K; Lucken R; van de Moer A; Houghton S; Simpson B; Cameron A; Monkton P; Hennesy K; Ellis C
    Dev Biol Stand; 1999; 101():261-6. PubMed ID: 10566800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation.
    Rosskopf-Streicher U; Johannes S; Gyra H; Beckmann R; Cussler K
    Dev Biol (Basel); 2002; 111():153-8. PubMed ID: 12678235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a modified Taqman assay detecting pathogenic Leptospira spp. against culture and Leptospira-specific IgM enzyme-linked immunosorbent assay in a clinical environment.
    Slack A; Symonds M; Dohnt M; Harris C; Brookes D; Smythe L
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):361-6. PubMed ID: 17188447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International regulatory requirements for Leptospira vaccine potency testing. Roundtable: current requirements and opportunity for harmonization.
    Draayer HA; Bruckner L; Peña-Moctezuma Ade L; Srinivas G
    Biologicals; 2013 Sep; 41(5):305-7. PubMed ID: 23890730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.